Molecular cloning and characterization of olive flounder (Paralichthys olivaceus) peroxisome proliferator-activated receptor γ

被引:32
作者
Cho, Hyun Kook [1 ]
Kong, Hee Jeong [2 ]
Nam, Bo-Hye [2 ]
Kim, Woo-Jin [2 ]
Noh, Jae-Koo [2 ]
Lee, Jeong-Ho [2 ]
Kim, Young-Ok [2 ]
Cheong, JaeHun [1 ]
机构
[1] Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea
[2] Natl Fisheries Res & Dev Inst, Biotechnol Res Ctr, Pusan 619902, South Korea
关键词
PPAR gamma; Nuclear hormone receptor; Olive flounder; Cloning; Transactivation; PPAR-GAMMA; FATTY-ACIDS; BINDING-PROTEIN; LIGAND-BINDING; EXPRESSION; IDENTIFICATION; ADIPOGENESIS; REGULATOR; ALPHA; LIVER;
D O I
10.1016/j.ygcen.2009.04.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that play key roles in lipid and energy homeostasis. Olive flounder (Paralichthys olivaceus) PPAR gamma cDNA (olPPAR gamma) was isolated by reverse transcription-polymerase chain reaction (RT-PCR) and rapid amplification of cDNA ends (RACE). The full-length cDNA is 1667-bp long and encodes a polypeptide with 532 amino acids containing a C4-type zinc finger and a ligand-binding domain. Quantitative RT-PCR revealed that olPPAR gamma transcription was detected from 7 days post-hatching, and its expression was increased under a starved condition. Overexpression of olPPAR gamma stimulated PPAR response element (PPRE) activity, and treatment with rosiglitazone, a PPAR gamma agonist, augmented olPPAR gamma-stimulated PPRE activity in HINAE olive flounder cells. Cotransfection of olPPAR gamma and olRXR beta, in the absence or presence of rosiglitazone and ciglitazone, produced a synergistic effect on PPRE transactivation in 3T3L1 adipocytes. Moreover, olPPAR gamma, in the presence or absence of rosiglitazone, regulated the expression of lipid synthesis- and adipogenesis-related proteins in NIH3T3 and 3T3L1 cells. Taken together, these results suggest that olPPAR gamma is functionally and evolutionarily conserved in olive flounder and mammals. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 42 条
[1]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[2]   Molecular characterization of three peroxisome proliferator-activated receptors from the sea bass (Dicentrarchus labrax) [J].
Boukouvala, E ;
Antonopoulou, E ;
Favre-Krey, L ;
Diez, A ;
Bautista, JM ;
Leaver, MJ ;
Tocher, DR ;
Krey, G .
LIPIDS, 2004, 39 (11) :1085-1092
[3]  
BRESSLER R, 1961, J BIOL CHEM, V236, P1643
[4]   A decade of molecular biology of retinoic acid receptors [J].
Chambon, P .
FASEB JOURNAL, 1996, 10 (09) :940-954
[5]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688
[6]   Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 [J].
Elbrecht, A ;
Chen, YL ;
Cullinan, CA ;
Hayes, N ;
Leibowitz, MD ;
Moller, DE ;
Berger, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) :431-437
[7]   Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene [J].
Frohnert, BI ;
Hui, TY ;
Bernlohr, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :3970-3977
[8]   Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass [J].
Gavrilova, O ;
Haluzik, M ;
Matsusue, K ;
Cutson, JJ ;
Johnson, L ;
Dietz, KR ;
Nicol, CJ ;
Vinson, C ;
Gonzalez, FJ ;
Reitman, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :34268-34276
[9]   Understanding adipocyte differentiation [J].
Gregoire, FM ;
Smas, CM ;
Sul, HS .
PHYSIOLOGICAL REVIEWS, 1998, 78 (03) :783-809
[10]   Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation [J].
Hutley, LJ ;
Newell, FM ;
Joyner, JM ;
Suchting, SJ ;
Herington, AC ;
Cameron, DP ;
Prins, JB .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (07) :574-581